Could a diabetes drug help treat blocked leg arteries? new study investigates
NCT ID NCT07340112
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This observational study will examine whether a protein called the GLP-1 receptor is more active in patients with severe leg artery disease compared to those with milder symptoms. Researchers will take one extra blood sample from 50 adults with peripheral artery disease to measure receptor levels and related inflammation. The goal is to see if drugs that target this receptor, already used for diabetes, might one day help treat this condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could point toward using GLP-1 receptor agonists as a new treatment for severe peripheral artery disease.
- What could go wrong
- This is an early observational study with only 50 participants, so results may not apply to all patients. It does not test any treatment directly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LIMB-THREATENING ISCHEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpitaux Universitaires de Strasbourg
Strasbourg, 67091, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a sound wave camera inside arteries save more legs?
- Can frailty predict stent failure? new study investigates
- New balloon coated with drug could save limbs in severe artery disease
- Can a simple walk predict vascular disease? new study investigates
- New ultrasound technique aims to save limbs in artery disease patients
- Tailored blood thinners could save limbs in PAD patients